HOME >> BIOLOGY >> NEWS
New diagnostic technology helps justify earlier cataract surgery

e eye. As cataracts increase in size and density, they reduce the amount of light passing through the lens, which results in blindness if not treated. In the U.S., Medicare, the federal government's health insurance program for the elderly, paid for 1.733 million procedures in 2002, according to the most recent data. Modern cataract treatment surgically removes the damaged lens and replaces it with an artificial one.

Because cataracts tend to grow gradually, one of the most important treatment issues is determining when they degrade vision to the point that the patient is at an increased risk of falls or accidents, or that their quality of life has been significantly undermined. (An August 2002, study reported in the Journal of the American Medical Association found that cataract patients who had surgery to treat the condition had 50 percent fewer car accidents than those patients who did not.)

Medicare and most insurance programs will pay the cost of cataract removal once a patient's vision has deteriorated to 20/50 or less when reading the standard (Snellen) eye chart, which was developed about 100 years ago. By contrast, states typically require at least 20/40 vision for driving without glasses.

Cataract patients often complain of glare, double vision, a shift in colors, and other problems. "There have been innumerable articles and textbook chapters noting that the Snellen test does not document the visual deficits experienced by cataract patients," said Samuel Masket, MD, chair of the Eye Surgery Education Council. While some insurance companies will cover the cost of cataract surgery based on additional testing, there is no widely accepted test that can corroborate patient's vision complaints.

"Patients are often in the position of having to curtail night driving because cataracts have made it dangerous or they have to cut back participation in other activities that enrich their lives
'"/>

Contact: Samuel Masket, MD
SamMasket@aol.com
310-229-1220
American Society of Cataract and Refractive Surgery
2-Aug-2004


Page: 1 2 3

Related biology news :

1. Yale digital diagnostic technology is basis of new company, HistoRx Inc.
2. New diagnostic tool brings effective treatment closer to patients
3. Nanoparticle probes are destined for major new role in medical diagnostics and drug delivery
4. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
5. Worlds leading mad cow diagnostic company, responds to USDAs additional BSE protection measures
6. Advances in prosthetic, orthopedic, and audiologic diagnostic tools
7. FDA clears for market new diagnostic test for lupus
8. New method of DNA testing promises to transform medical diagnostics
9. Leading lab expert to update medical community on diagnostic testing for thyroid function
10. AACR applauds NCI initiative on nanotechnology
11. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies

Post Your Comments:
(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
(Date:6/18/2013)... of breast and ovarian cancers are familial in origin, ... to inherited mutations from the parents in genes such ... PARP inhibitors, which are currently in clinical trials, have ... for personalised cancer treatment, an alternative to standard chemotherapy. ... these patients generate resistance to the drug and, therefore, ...
(Date:6/17/2013)... in the U.S. exposed to high levels of air pollution ... a child with autism as women who lived in areas ... School of Public Health (HSPH). It is the first large ... across the U.S. , "Our findings raise concerns since, depending ... our study lived in areas where risk of autism was ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
(Date:6/18/2013)... -- RegeneCure announced today the start ... Bone Regeneration (GBR) Dental Membrane as a bone stimulating aid ... encountered when patients have a tooth replaced with a dental ... the implant. Consequently there is often a need to support ... regenerates. The bone substitute material, in turn, needs to be ...
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
Cached News: